![Roger Mills](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Roger Mills
Chief Tech/Sci/R&D Officer at
ADDEX THERAPEUTICS LTD
Net worth: 39 362 $ as of 30/06/2026
Profile
Dr. Roger G.
Mills, MD, is a Non-Executive Director & Chief Medical Officer at Addex Therapeutics Ltd. and a Director & Executive Vice President at San Diego Opera.
He is on the Board of Directors at Enterin, Inc., Addex Therapeutics Ltd. and San Diego Opera.
Dr. Mills was previously employed as a Chief Medical Officer & Executive VP-Development by ACADIA Pharmaceuticals, Inc., a Principal by Gilead Sciences, Inc., a Vice President-Development by Pfizer (St. Louis), and a Principal by Wellcome Foundation Ltd. He received his doctorate degree from Charing Cross Hospital Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 18/03/2026 | 7,85,976 ( 0.36% ) | 39 362 $ | 30/06/2026 |
Roger Mills active positions
| Companies | Position | Start |
|---|---|---|
| ADDEX THERAPEUTICS LTD | Chief Tech/Sci/R&D Officer | 28/11/2016 |
San Diego Opera
 San Diego Opera Movies/EntertainmentConsumer Services Operates as a opera company | Director/Board Member | - |
Enterin, Inc.
 Enterin, Inc. BiotechnologyHealth Technology Develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease | Director/Board Member | 13/09/2021 |
Former positions of Roger Mills
| Companies | Position | End |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 04/11/2015 |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Corporate Officer/Principal | - |
Wellcome Foundation Ltd
 Wellcome Foundation Ltd Commercial Printing/FormsCommercial Services Engages in priniting activities | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
Training of Roger Mills
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
57
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
ACADIA Pharmaceuticals, Inc.
 ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
Wellcome Foundation Ltd
Wellcome Foundation Ltd Commercial Printing/FormsCommercial Services Engages in priniting activities | Commercial Services |
Addex Therapeutics Ltd.
 Addex Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Provides research services in prescription medicines for humans and animals | Health Technology |
San Diego Opera
San Diego Opera Movies/EntertainmentConsumer Services Operates as a opera company | Consumer Services |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease | Health Technology |
Charing Cross Hospital Medical School
 Charing Cross Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Roger Mills
